
(© TanyaJoy - stock.adobe.com)
Why Your Heart Health Checkup Might Say Something About Your Brain
In A Nutshell
- A weaker heart pump, measured by a routine number called ejection fraction, was linked to brain tissue disruption showing up more than three years later.
- This link appeared even in patients who did not have diagnosed heart failure, not just those with the condition.
- The affected brain regions overlap with areas considered vulnerable early in Alzheimer’s disease, though amyloid and tau were not measured.
- Statistical analysis suggested this brain disruption helps explain the connection between weaker heart pumping and poorer memory, though the study cannot prove cause and effect.
A number buried in a standard echocardiogram report, one most patients never think twice about, may be linked to memory trouble years down the road. New research out of Germany found that a weaker heart pump was associated with specific brain differences showing up more than three years later, in regions tied to memory, a pattern strong enough to appear even in people who did not meet the study’s threshold for heart failure at the start.
Published in the Journal of Neuroscience, the study followed 73 patients for an average of three and a half years, comparing two heart measurements at the outset against brain scans and memory tests done years later. Patients with weaker pumping ability at the start showed more signs of microscopic disruption in memory-related brain regions when scanned years afterward.
Reduced heart function often causes no symptoms in its early stages, part of what makes these findings notable. A measurement ordinarily filed in a cardiologist’s chart, one that has nothing to do with the brain on its face, may carry information about cognitive risk that has gone largely unexamined.
How Scientists Tracked the Heart-Brain Link Over Time
Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences recruited patients from the Leipzig Heart Study, a long-running project involving people evaluated for coronary artery disease. The final group of 73 included 33 patients classified as having heart failure, 37 classified as not having heart failure, and three whose blood-marker results fell into an in-between range and were analyzed only as part of the full group. The original heart-failure and comparison groups were selected to be similar in age, sex, smoking status, diabetes, and several vascular risk measures. Average age was about 55, and men made up the majority of participants, at 53 out of 73.
Each patient had two heart measurements taken at the outset. The first, ejection fraction, is the number an echocardiogram gives to describe how much blood the heart pushes out with each beat, essentially a measure of pumping strength. The second, NT-proBNP, is a blood marker that rises when the heart is under strain, working more like an alarm bell than a direct measure of pump function.
Roughly three and a half years later, patients returned for a brain scan using a specialized MRI technique called diffusion tensor imaging. Rather than looking for shrinkage, the method most earlier studies relied on, this approach measures how freely water molecules move through brain tissue, since that movement can shift when the microscopic structure of brain tissue becomes less intact, often well before anything shows up on a standard scan. Patients also completed a full battery of memory and thinking tests covering attention, problem-solving, and both verbal and visual memory.
Weaker Heart Pumping Was Linked to Brain Differences Even Without Diagnosed Heart Failure
Patients with a lower ejection fraction at the start, meaning a weaker pump, showed more of this water-movement difference years later, and this held true even among patients who did not have diagnosed heart failure when the study began. Higher NT-proBNP levels were linked to the same difference, but mainly in patients who already had heart failure. Ejection fraction was associated with brain differences even outside the heart-failure group, while the NT-proBNP pattern was strongest among those already classified as having heart failure.
In both cases, the disruption clustered in brain regions tied to memory, regions that overlap with some areas considered vulnerable early in Alzheimer’s disease.
Brain Tissue Disruption May Help Explain the Memory Link
A statistical technique called mediation analysis let researchers test whether brain measurements could statistically help explain the link between weaker heart pumping and poorer memory, rather than the two simply appearing side by side. The analysis suggested they could: a weaker heart predicted more brain tissue disruption, which was linked to worse memory scores. Once researchers accounted for those brain measurements, they no longer found a statistically significant direct association between ejection fraction and memory on its own.
Sample size was modest, and the researchers acknowledge that a single follow-up scan cannot fully establish cause and effect, since it captures brain measurements at only one point rather than tracking changes from a baseline. They also lacked biomarkers for amyloid or tau, the proteins associated with Alzheimer’s disease, so any overlap with that condition remains circumstantial rather than confirmed. Still, the team ran their analysis through multiple technical checks, including corrections for scanning artifacts and brain shrinkage, and the same pattern held up each time.
According to the authors, cardiac dysfunction is tied to a predictable pattern of brain tissue disruption that conventional scans may miss, and this disruption helps explain memory difficulties linked to heart problems, making brain tissue health a possible focus for future studies aimed at protecting cognitive health. Ejection fraction cannot currently predict an individual patient’s memory problems, and the findings need confirmation in larger groups before any clinical use.
Still, subtle changes in heart pumping may carry clues about brain health before memory problems become obvious, and catching those clues early could eventually help protect memory.
Disclaimer: This article summarizes findings from a single peer-reviewed observational study and is intended for general informational purposes only. It does not constitute medical advice, and the heart measurements discussed are not validated tools for predicting individual memory or cognitive outcomes. Anyone with concerns about heart health, memory, or cognitive function should consult a qualified healthcare provider.
Paper Notes
Limitations
The study’s authors note several constraints. The research design was observational, with only one brain scan taken after the initial heart measurements, which limits how firmly cause and effect can be established. The team also lacked biomarkers for amyloid or tau proteins, so while the affected brain regions overlap with those affected in Alzheimer’s disease, a direct link to that condition could not be confirmed. Technical limits of the imaging protocol prevented a correction technique called free-water correction, and the absence of certain reference scans ruled out one standard distortion-correction method, though the researchers used alternative correction pipelines and found consistent results. The modest sample size of 73 patients likely reduced statistical power for detecting some direct effects, and the group of patients without heart failure included a mix of people with and without underlying structural heart disease, which may have diluted some subgroup findings.
Funding and Disclosures
The research was supported by the Chinese Science Council and by German public funding sources, including the Sächsische Aufbaubank and the European Union’s European Regional Development Fund. The study was co-financed with tax revenue approved by the Saxon state parliament. The authors reported no competing financial interests.
Publication Details
The study, titled “Mapping the Heart–Brain Continuum beyond Heart Failure: Why Neurology Matters,” was authored by Xia Zhang, Khosrov A. Grigoryan, Nico Scherf, Qiong Wu, Arno Villringer, Matthias L. Schroeter, and Karsten Mueller. It was published in the Journal of Neuroscience (JNeurosci) as an early-release, peer-reviewed article, accepted May 28, 2026. The paper’s DOI is 10.1523/JNEUROSCI.2274-25.2026. Corresponding authors are Xia Zhang and Karsten Mueller of the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.







